Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-16-151300

SVP & Chief Scientific Officer sold 670 shares at $13.96 ($9,353)

From the SEC's structured data for this filing

Trades in this filing

Doberstein Stephen K · SVP & Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-11-16 Sale : show line 1 in the form −670 $13.96 $9,353 18,265 D
Open-market sales · 670 sh · avg $13.96 · $9,353
Loading xslF345X03/doc4.xml…